GSK's vac­cine arm lays claim to a ma­jor break­through on tu­ber­cu­lo­sis

Glax­o­SmithK­line’s vac­cines group is herald­ing a “sci­en­tif­ic break­through” on tu­ber­cu­lo­sis, point­ing to hard ev­i­dence that an ex­per­i­men­tal jab of theirs can pro­tect rough­ly half the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER